{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:34:53Z","timestamp":1763019293032,"version":"3.45.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.idnow.2022.08.003","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T23:07:18Z","timestamp":1661641638000},"page":"396-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France"],"prefix":"10.1016","volume":"52","author":[{"given":"Marion","family":"Lecuru","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00f4me","family":"Daniau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Alfandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Dumartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Bajolet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herv\u00e9","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lo\u00efc","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Anne-Berger-Carbonne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lanie","family":"Colomb-Cotinat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.idnow.2022.08.003_b0005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01076-18","article-title":"Past and Present Perspectives on \u03b2-Lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idnow.2022.08.003_b0010","unstructured":"Mission Spares. Surveillance de la consommation des antibiotiques et des r\u00e9sistances bact\u00e9riennes en \u00e9tablissement de sant\u00e9. Mission SPARES, r\u00e9sultats 2019. Saint-Maurice: Sant\u00e9 publique France; 2020. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-associees-aux-soins-et-resistance-aux-antibiotiques\/resistance-aux-antibiotiques\/documents\/enquetes-etudes\/surveillance-de-la-consommation-des-antibiotiques-et-des-resistances-bacteriennes-en-etablissement-de-sante.-mission-spares-resultats-2019, January 2022"},{"issue":"2","key":"10.1016\/j.idnow.2022.08.003_b0015","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00047-19","article-title":"Epidemiology of \u03b2-Lactamase-Producing Pathogens","volume":"33","author":"Bush","year":"2020","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.idnow.2022.08.003_b0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/37.1.203","article-title":"Treatment failure due to extended spectrum beta-lactamase","volume":"37","author":"Karas","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2022.08.003_b0025","unstructured":"Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9. Strat\u00e9gie nationale 2022-2025 de pr\u00e9vention des infections et de l'antibior\u00e9sistance. Paris: Minist\u00e8re des solidarit\u00e9s et de la sant\u00e9; 2022 February 2022. https:\/\/solidarites-sante.gouv.fr\/actualites\/presse\/communiques-de-presse\/article\/le-ministere-des-solidarites-et-de-la-sante-presente-la-strategie-nationale, March 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0030","unstructured":"1\u00e8re r\u00e9union du comit\u00e9 interminist\u00e9riel pour la sant\u00e9 : ma\u00eetriser la r\u00e9sistance bact\u00e9rienne aux antibiotiques - 13 grandes mesures interminist\u00e9rielles : 40 actions. Paris: Comit\u00e9 interminist\u00e9riel pour la sant\u00e9; 2016. https:\/\/solidarites-sante.gouv.fr, May 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0035","unstructured":"Haut Conseil de la sant\u00e9 publique. Recommandations relatives aux mesures \u00e0 mettre en \u0153uvre pour pr\u00e9venir l\u2019\u00e9mergence des ent\u00e9robact\u00e9ries BLSE et lutter contre leur diss\u00e9mination. Paris: HCSP; 2010. https:\/\/www.hcsp.fr\/explore.cgi\/avisrapportsdomaine?clefr=162, May 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0040","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals \u2013 protocol version 5.3. . Stockholm: ECDC; 2016. https:\/\/www.ecdc.europa.eu\/en\/healthcare-associated-infections-acute-care-hospitals\/surveillance-disease-data\/protocol, May 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0045","doi-asserted-by":"crossref","unstructured":"Sevin T, Daniau C, Alfandari S, Piednoir E, Dumartin C, Blanchard H, et al. Patterns of antibiotic use in hospital-acquired infections. 2021 Aug;114:104-10.doi: 10.1016\/j.jhin.2021.05.008.","DOI":"10.1016\/j.jhin.2021.05.008"},{"key":"10.1016\/j.idnow.2022.08.003_b0050","unstructured":"Haute autorit\u00e9 de sant\u00e9. Antibioth\u00e9rapie des infections \u00e0 ent\u00e9robact\u00e9ries et \u00e0 Pseudomonas aeruginosa chez l\u2019adulte : place des carbap\u00e9n\u00e8mes et de leurs alternatives. Paris: HAS; 2019. https:\/\/www.has-sante.fr\/jcms\/c_2968915\/fr\/antibiotherapie-des-infections-a-enterobacteries-et-a-pseudomonas-aeruginosa-chez-l-adulte-place-des-carbapenemes-et-de-leurs-alternatives, May 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0055","unstructured":"R\u00e9seau d\u2019alerte, d\u2019investigation et de surveillance des infections nosocomiales (Raisin). Enqu\u00eate nationale de pr\u00e9valence 2012 des infections nosocomiales et des traitements anti-infectieux en \u00e9tablissements de sant\u00e9 - Mai - juin 2012 - Protocole\/Guide de l\u2019enqu\u00eateur. Saint-Maurice: Institut de veille sanitaire; 2012. https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/infections-associees-aux-soins-et-resistance-aux-antibiotiques\/infections-associees-aux-soins\/documents\/rapport-synthese\/enquete-nationale-de-prevalence-2012-des-infections-nosocomiales-et-des-traitements-anti-infectieux-en-etablissements-de-sante.-mai-juin-2012.-prot, May 2022."},{"key":"10.1016\/j.idnow.2022.08.003_b0060","unstructured":"Sant\u00e9 publique France. Enqu\u00eate nationale de pr\u00e9valence 2017 des infections nosocomiales et des traitements antiinfectieux en \u00e9tablissements de sant\u00e9. Guide de l\u2019enqu\u00eateur. Saint-Maurice: Sant\u00e9 publique France; 2017. http:\/\/www.cpias.fr\/ES\/surveillance\/prevalence.html, May 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0065","unstructured":"European Centre for Disease Prevention and Control. Point prevalence survey of healthcareassociated infections and antimicrobial use in European acute care hospitals \u2013 protocol version 4.3. Stockholm: ECDC; 2012. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/point-prevalence-survey-healthcare-associated-infections-and-antimicrobial-use, May 2022."},{"key":"10.1016\/j.idnow.2022.08.003_b0070","unstructured":"Soci\u00e9t\u00e9 de pathologie infectieuse de langue fran\u00e7aise. R\u00e9vision des recommandations de bonne pratique pour la prise en charge et la pr\u00e9vention des Infections Urinaires Associ\u00e9es aux Soins (IUAS) de l\u2019adulte. Paris: SPILF; 2015. https:\/\/www.sf2h.net\/publications\/bonne-pratique-prise-charge-prevention-infections-urinaires-associees-aux-soins-iuas-de-ladulte, May 2022."},{"key":"10.1016\/j.idnow.2022.08.003_b0075","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Annexe 1 \u2013 argumentaire pour les recommandations faites en 2011 \u00e0 propos des c\u00e9phalosporines de 3e g\u00e9n\u00e9ration et l\u2019aztr\u00e9onam vis-\u00e0-vis des ent\u00e9robact\u00e9ries. Paris: SFM; 2018. https:\/\/www.google.com\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwjqqafCs4n4AhUIuRoKHZ1XCz8QFnoECAUQAQ&url=https%3A%2F%2Fwww.infectiologie.com%2FUserFiles%2FFile%2Fmedias%2FRecos%2F2011-Argu-Reco-CaSFM.pdf&usg=AOvVaw3zhZc-e9uztl6aY7UMkjwI, May 2022"},{"key":"10.1016\/j.idnow.2022.08.003_b0080","unstructured":"AFFSAPS, GPIP, SPILF. Mise au point sur le bon usage des aminosides administr\u00e9s par voie injectable : gentamycine, tobramycine, n\u00e9tilmycine, amikacine Mars 2011. https:\/\/www.preventioninfection.fr\/document\/mise-au-point-sur-le-bon-usage-des-aminosides-administres-par-voie-injectable-gentamicine-tobramycine-netilmicine-amikacine\/, May 2022."}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991922001798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991922001798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T07:31:26Z","timestamp":1763019086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991922001798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2666991922001798"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2022.08.003","relation":{},"ISSN":["2666-9919"],"issn-type":[{"type":"print","value":"2666-9919"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2022.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}